September 21, 2021
According to the business intelligence report titled ‘Global Anti-acne Cosmetics Market By Product Type (Mask, Creams & Lotions, Cleansers & Toners), By End-use (Women, Men), Regional Forecasts 2021-2027’, available with Market Study Report, global anti-acne cosmetics market is speculated to witness significant growth between 2021-2027.
High prevalence of acne, social stigma associated with it, and increasing use of cosmetic products by men & women alike in developing countries are the key growth stimulants for global anti-acne cosmetics market.
Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3891237/
As per the European Academy of Dermatology and Venerology, 95% of boys and 85% of girls have acne in teenage. Approximately, 40% of them have moderate to severe acne, while 50% still have acne after teenage.
For the unversed, acne is a commonly occurring skin disease which results in lesions known as zits or pimples. Scientifically known as acne vulgaris, it is the most frequent skin problem suffered by teenagers. Anti-acne products result in the cleaning of pimples, whiteheads, and other types of infection.
Increasing urbanization, growing internet penetration, and rising number of e-commerce platforms will aid industry growth over the analysis period. On the other hand, rising popularity of acne therapeutics will act as a challenge for businesses in this domain.
Based on product gamut, worldwide anti-acne cosmetics market is split into creams & lotions, mask, cleansers & toners, and others. Speaking of end user spectrum, the industry is divided into women, and men.
Regionally, North America accounted for majority industry share in the recent past due to high vulnerability to depression, anxiety, dejection, and low confidence among people suffering from acne vulgaris. Growing number of e-commerce sites, increasing internet penetration, and growing awareness among consumers will aid revenue inflow as well.
Key players profiled in global anti-acne cosmetics market report are Proactiv Company LLC, Ancalima Lifesciences Ltd., Neutrogena Corporation, Kosé Corporation, L'Oréal S.A., Mentholatum Company Inc., DoctorLi, Vichy (L'Oréal S.A.), Clinique Laboratories LLC, and La Roche-Posay Laboratoire Dermatologique (L'Oréal S.A.).
These companies have undertaken strategic decisions such as product launches, investments in R&D, mergers & acquisitions, partnerships, and collaborations, thus amassing massive revenues, and maximizing profits.